Comments
Loading...
Inhibrx Biosciences Insider Trading Activity | NASDAQ:INBX | Benzinga
Track the latest Inhibrx Biosciences insider trading activity. Stay informed on recent buys, sells, and market impact for Inhibrx Biosciences stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Inhibrx Biosciences Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Inhibrx Biosciences Inc
Shares Outstanding
14.476M
Insider Shares Owned
20.443K
Insider Percentage Owned
0.14%
Institutional Shares Held
2.580M
Institutional Percentage Held
17.8%
| Nov 22, 2024 | Jon Faiz Kayyem | DIRECTOR | 107.19K | $14.21 | $1.52M | BUY | ∞ | 69.84K | Nov 19 - Nov 20 | View |
| Oct 07, 2024 | Kelly Deck as attorney-in-fact to Kristiina Vuori | DIRECTOR | 6.67K | $15.00 | $100.00K | BUY | 48.40% | 20.44K | Oct 03 | View |
| Sep 16, 2024 | Mark Lappe | CHIEF EXECUTIVE OFFICER | 40.00K | $15.73 | $629.12K | BUY | 5.55% | 760.41K | Sep 12 - Sep 16 | View |
| Sep 12, 2024 | Kelly Deck as attorney-in-fact to Kristiina Vuori | DIRECTOR | 6.64K | $15.07 | $99.99K | BUY | 92.94% | 13.78K | Sep 10 - Sep 11 | View |
| Sep 10, 2024 | Mark Lappe | CHIEF EXECUTIVE OFFICER | 44.00K | $15.25 | $671.15K | BUY | 6.50% | 720.41K | Sep 06 - Sep 10 | View |
| Sep 03, 2024 | Mark Lappe | CHIEF EXECUTIVE OFFICER | 40.00K | $14.92 | $596.76K | BUY | 22.24% | 219.87K | Aug 29 - Sep 03 | View |
| Sep 03, 2024 | Kelly Deck as attorney-in-fact to Kristiina Vuori | DIRECTOR | 7.14K | $14.00 | $99.96K | BUY | ∞ | 7.14K | Aug 29 | View |
| Aug 30, 2024 | Kimberly Manhard | DIRECTOR | 10.00K | $13.98 | $139.80K | BUY | ∞ | 10.00K | Aug 28 | View |
| Aug 26, 2024 | Douglas Forsyth | DIRECTOR | 75.00K | $13.83 | $1.04M | BUY | 50.15% | 224.56K | Aug 22 - Aug 23 | View |
| Aug 22, 2024 | Mark Lappe | CHIEF EXECUTIVE OFFICER | 40.00K | $12.96 | $518.28K | BUY | 28.60% | 179.87K | Aug 20 - Aug 21 | View |
| Jun 07, 2024 | Jon Faiz Kayyem | DIRECTOR | 57.55K | $17.32 | $997.02K | BUY | 5.27% | 1.15M | Jun 05 | View |
| Jun 04, 2024 | Jon Faiz Kayyem | DIRECTOR | 286.79K | $17.18 | $4.93M | BUY | 35.58% | 1.09M | May 31 - Jun 04 | View |
| May 30, 2024 | Brendan Eckelman | CHIEF SCIENTIFIC OFFICER | -2.36M | $30.55 | -$71.96M | SELL | -100.00% | 0.00 | May 28 - May 30 | View |
| Aug 30, 2023 | VIKING GLOBAL INVESTORS LPViking Global Opportunities GP LLCViking Global Opportunities Parent GP LLCANDREAS OLE HALVORSENDavid OttSharon Rose Shabet | — | 511.63K | $19.35 | $9.90M | BUY | 13.19% | 4.39M | Aug 28 | View |
| Mar 02, 2023 | Brendan EckelmanEckelman Living Trust Dated February | CHIEF SCIENTIFIC OFFICER | -40.00K | $24.21 | -$968.23K | SELL | -1.79% | 2.20M | Mar 01 | View |
| Mar 01, 2023 | Mark LappeLappe Family Trust | CHIEF EXECUTIVE OFFICER | -60.00 | $25.02 | -$1.50K | SELL | -0.00% | 2.55M | Feb 28 | View |
| Feb 02, 2023 | Brendan EckelmanEckelman Living Trust Dated February | CHIEF SCIENTIFIC OFFICER | -40.00K | $24.93 | -$997.21K | SELL | -1.76% | 2.24M | Feb 01 - Feb 02 | View |
| Jan 24, 2023 | Mark LappeLappe Family Trust | CHIEF EXECUTIVE OFFICER | -26.00K | $25.42 | -$660.84K | SELL | -1.01% | 2.55M | Jan 23 - Jan 24 | View |
| Jan 23, 2023 | Faiz Jon Kayyem | DIRECTOR | -9.50K | $25.26 | -$240.00K | SELL | -0.29% | 3.25M | Jan 23 | View |
| Jan 04, 2023 | Brendan EckelmanEckelman Living Trust Dated February | CHIEF SCIENTIFIC OFFICER | -40.00K | $23.71 | -$948.60K | SELL | -1.73% | 2.28M | Jan 03 - Jan 04 | View |
| Dec 22, 2022 | Faiz Jon Kayyem | DIRECTOR | -9.50K | $27.02 | -$256.68K | SELL | -0.29% | 3.26M | Dec 21 | View |
| Dec 20, 2022 | Mark LappeLappe Family Trust | CHIEF EXECUTIVE OFFICER | -26.00K | $25.56 | -$664.44K | SELL | -1.00% | 2.57M | Dec 19 | View |
| Dec 07, 2022 | Brendan EckelmanEckelman Living Trust Dated February | CHIEF SCIENTIFIC OFFICER | -40.00K | $27.22 | -$1.09M | SELL | -1.70% | 2.32M | Dec 06 | View |
| Nov 22, 2022 | Faiz Jon Kayyem | DIRECTOR | -9.50K | $29.89 | -$283.97K | SELL | -0.29% | 3.27M | Nov 21 | View |
| Nov 18, 2022 | Mark LappeLappe Family Trust | CHIEF EXECUTIVE OFFICER | -26.00K | $27.88 | -$724.91K | SELL | -0.99% | 2.60M | Nov 17 | View |
| Nov 02, 2022 | Brendan EckelmanEckelman Living Trust Dated February | CHIEF SCIENTIFIC OFFICER | -40.00K | $33.51 | -$1.34M | SELL | -1.67% | 2.36M | Nov 01 | View |
| Oct 24, 2022 | Faiz Jon Kayyem | DIRECTOR | -9.50K | $30.13 | -$286.23K | SELL | -0.29% | 3.28M | Oct 21 | View |
| Oct 18, 2022 | Mark LappeLappe Family Trust | CHIEF EXECUTIVE OFFICER | -26.00K | $29.59 | -$769.44K | SELL | -0.98% | 2.62M | Oct 17 | View |
| Oct 12, 2022 | VIKING GLOBAL INVESTORS LPViking Global Opportunities Illiquid Investments SubMaster LPViking Global Opportunities Portfolio GP LLCViking Global Opportunities GP LLCDRAGSA LLCANDREAS OLE HALVORSENDavid OttSharon Rose Shabet | — | 1.33M | $30.00 | $40.00M | BUY | 46.32% | 4.21M | Oct 07 | View |
| Oct 05, 2022 | Brendan EckelmanEckelman Living Trust Dated February | CHIEF SCIENTIFIC OFFICER | -40.00K | $27.82 | -$1.11M | SELL | -1.64% | 2.40M | Oct 04 | View |
| Sep 07, 2022 | Brendan EckelmanEckelman Living Trust Dated February | CHIEF SCIENTIFIC OFFICER | -40.00K | $14.91 | -$596.27K | SELL | -1.57% | 2.52M | Sep 06 | View |
| Aug 04, 2022 | Brendan EckelmanEckelman Living Trust Dated February | CHIEF SCIENTIFIC OFFICER | -40.00K | $18.00 | -$719.83K | SELL | -1.54% | 2.56M | Aug 02 - Aug 03 | View |
| Jul 08, 2022 | Brendan EckelmanEckelman Living Trust Dated February | CHIEF SCIENTIFIC OFFICER | -40.00K | $17.17 | -$686.80K | SELL | -1.52% | 2.60M | Jul 07 | View |
| Apr 07, 2022 | Brendan EckelmanEckelman Living Trust Dated February | CHIEF SCIENTIFIC OFFICER | -400.00 | $25.04 | -$10.02K | SELL | -0.02% | 2.64M | Apr 05 | View |
| Mar 24, 2021 | Brendan EckelmanFebruary Dated Trust Living Eckelman | CHIEF SCIENTIFIC OFFICER | -17.00K | $19.02 | -$323.34K | SELL | -0.64% | 2.64M | Mar 24 | View |
| Feb 18, 2021 | Brendan EckelmanFebruary Dated Trust Living Eckelman | CHIEF SCIENTIFIC OFFICER | -17.00K | $25.90 | -$440.30K | SELL | -0.64% | 2.65M | Feb 16 | View |
| Feb 18, 2021 | Klaus Wagner | CHIEF MEDICAL OFFICER | -176.03K | $24.43 | -$4.30M | SELL | -45.00% | 215.15K | Feb 16 - Feb 17 | View |
| Aug 28, 2020 | VIKING GLOBAL INVESTORS LPViking Global Opportunities Illiquid Investments SubMaster LPViking Global Opportunities Portfolio GP LLCViking Global Opportunities GP LLCDRAGSA LLCANDREAS OLE HALVORSENDavid OttSharon Rose Shabet | — | 180.22K | $18.92 | $3.41M | PURCHASE | 3.52% | 5.31M | Aug 26 | View |
| Aug 25, 2020 | VIKING GLOBAL INVESTORS LPViking Global Opportunities Illiquid Investments SubMaster LPViking Global Opportunities Portfolio GP LLCViking Global Opportunities GP LLCDRAGSA LLCANDREAS OLE HALVORSENDavid OttSharon Rose Shabet | — | 131.47K | $19.39 | $2.55M | PURCHASE | 2.63% | 5.13M | Aug 24 - Aug 25 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.